Cancer of the Breast
New England Journal of MedicinePublished 3 January 1980
I. Craig Henderson, George P. Canellos
Citations468
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
Abstract
TWELVE years ago in the Journal, Dr. F. D. Moore and his colleagues evaluated the various forms of therapy then current for the treatment of both primary and metastatic breast carcinoma.1 In 1967 most patients with breast cancer were treated initially with mastectomy, and at the time of relapse one of various endocrine treatments was employed. This is still true in the United States.2 , 3 However, there has been a plateau in the survival curves of breast-cancer patients since about 1955.4 As a result, therapeutic approaches based on new concepts of the disease, some of these approaches merely mentioned in . . .
Keywords
Computer ScienceMedicineBiochemistry, Genetics and Molecular Biology
New England Journal of MedicineCombination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer
1,334 Citations1976Gianni Bonadonna, Ercole Brusamolino +9 more
Long-term chemotherapy produced an acceptable toxicity, thus allowing the administration of a high percentage of drug dosage, and the effect of this therapy on survival and possible long-term side effects remain unknown.
The LancetON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1
1,277 Citations1896GeorgeThomas Beatson
American Journal of RoentgenologyBreast patterns as an index of risk for developing breast cancer
915 Citations1976Wolfe Jn
A restrospective study of 7,214 patients placed into one of four groups of risk for developing carcinoma of the breast found that there was a 37 times greater incidence for those at highest risk compared to the low risk group.
CancerThe pathology of invasive breast cancerA Syllabus Derived from Findings of the National Surgical Adjuvant Breast Project (Protocol No. 4)
750 Citations1975Edwin R. Fisher, Remigio M. Gregorio +5 more
It becomes evident that the guidelines followed in the examination of these specimens appear to represent at least the minimum requirements necessary for a meaningful pathologic evaluation of breast carcinoma.
PubMedEstrogen receptor as an independent prognostic factor for early recurrence in breast cancer.
706 Citations1977William A. Knight, Robert B. Livingston +2 more
The usefulness of estrogen receptor measurements in primary breast tumors in the prediction of early recurrence was examined in a series of 145 patients and the absence of estrogenceptor in such tumors was associated withEarly recurrence independent of other known prognostic factors.
CancerEvidence on screening for breast cancer from a randomized trial
577 Citations1977Sam Shapiro
Based on current findings in the HIP study, there appears to be strong support for periodic screening at ages 50 years and over with clinical examination and mammography; to justify screening under 50, new information from other studies is required.
CancerLobular neoplasia (so-called lobular carcinoma in situ) of the breast
524 Citations1978C. D. Haagensen, Nathan Lane +2 more
The ratio between the observed and expected numbers of patients developing carcinoma in the several possible combinations of these three factors which predispose to carcinoma is determined: in patients in whom all three predisposing factors were present the ratio of observed to expected risk of carcinoma was 13:8.
CancerCancer of the breast: Size of neoplasm and prognosis
485 Citations1969Bernard Fisher, Nelson H. Slack +2 more
It is concluded that size may not necessarily relate to “earliness” or “lateness” of a tumor, nor is it as consequential to the fate of the patient as are other factors relative to the tumor and /or host that may be present from its inception and which determine the development of metastases.
New England Journal of MedicineAcute Leukemia after Alkylating-Agent Therapy of Ovarian Cancer
453 Citations1977Ronald Reimer, Robert N. Hoover +2 more
BMJTreatment of Early Breast Cancer: A Report after Ten Years of a Clinical Trial
431 Citations1972H. J. B. Atkins, J.L. Hayward +2 more
In patients with clinically involved axillary nodes there was a significantly higher incidence of local and distant recurrence in those having a wide excision, and the survival of these patients was significantly less than those who had a radical mastectomy.
CancerComparison of radical mastectomy with alternative treatments for primary breast cancer:A first report of results from a prospective randomized clinical trial
431 Citations1977Bernard Fisher, Eleanor D. Montague +19 more
The American Journal of Surgical PathologyLobular carcinoma in situ of the breast Detailed analysis of 99 patients with average follow-up of 24 years
372 Citations1978Paul Peter Rosen, Philip Lieberman +3 more
It is considered prudent in most cases to recommend ipsilateral mastectomy with low axillary dissection and concurrent biopsy of the opposite breast, and Contralateral mastectomy is most appropriate when carcinoma is detected in the biopsy.
CancerCyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer
364 Citations1977Hiroki Koyama, Tomio Wada +7 more
It is found that CY induced primary ovarian failure in patients with breast cancer receiving prolonged daily administration of this agent after radical surgery, and no ovarian follicle was histologically found in three amenorrheic patients who underwent therapeutic oopho‐rectomy after CY therapy.
The Journal of Clinical Endocrinology & MetabolismAminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*
340 Citations1978Richard J. Santen, Steven J. Santner +4 more
In vitro studies demonstrated that aminoglutethimide (AG), a drug previously used as an adrenal steroidogenesis inhibitor, is also a potent aromatase blocker, and in vivo effects of AG on the rate of aromatization of δ4-A to E1 by direct radioisotopic kinetic methods were examined.
PubMedHormone receptors: their role in predicting prognosis and response to endocrine therapy.
335 Citations1978William McGuire
This review highlights some of the recent advances in the use of steroid receptors for management of breast cancer patients and pinpoints needs for future clinical trials.
Annals of SurgeryPostoperative Radiotherapy in the Treatment of Breast Cancer
316 Citations1970Bernard Fisher, Nelson H. Slack +3 more
CancerLong-term followup of breast cancer patients: The 30-year report
316 Citations1974Frank E. Adair, John Berg +2 more
A cohort of 1458 breast cancer patients treated by radical mastectomy in the years 1940–1943 has been followed since that time, and sixty‐nine seem to have been definitely lost to followup, while followup is active but incomplete for 30 others.
European Journal of Cancer (1965)Relation between the pathological nature and the growth rate of human tumors
310 Citations1971A Charbit, E.P. Malaise +1 more
This analysis shows that the various types of tumors may be ranked with respect to their increasing D.T: embryonal carcinomas, lymphomas, malignant mesenchymal tumors, squamous cell carcinomas and adenocarcinomas.
CancerConservative management of operable breast cancer.Ten years experience at the Foundation Curie
287 Citations1978R Calle, J.P. Pilleron +2 more
The authors' conservative treatment resulted in survival at five and ten years comparable to those of radical surgery, and two‐thirds of patients, alive at five years, had a preserved breast.
New England Journal of MedicineThe Relation between Estrogen Receptors and Response Rate to Cytotoxic Chemotherapy in Metastatic Breast Cancer
284 Citations1978Marc E. Lippman, Joseph C. Allegra +8 more
It is concluded that estrogen-receptor values are an important predictor of response to cytotoxic chemotherapy in metastatic breast cancer.
BMJHormonal profiles after the menopause.
272 Citations1976Sudip Chakravarti, William P. Collins +4 more
The concentrations of both oestrone and oestradiol remained consistently low for 10 years after the menopause, but ostradiol concentrations inexplicably increased in the last two decades, with levels at the lower end of normal range for reproductive women in six patients.
BMJNatural History of Untreated Breast Cancer (1805-1933)
257 Citations1962H. J. G. Bloom, W Richardson +1 more
There is no general agreement on the best treatment for patients with operable carcinoma of the breast, and McKinnon and also Park and Lees (1951) go so far as to doubt whether the methods of treatment employed for breast cancer at the present time have any value at all in prolonging life.
Annals of Internal MedicineMammography: A Contrary View
242 Citations1976John C. Bailar
There is good evidence that annual history, physical examination, and mammography can reduce short-term and midrange breast cancer mortality by about one third and promotion of mammography as a general public health measure is premature.
CancerRadical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an international cooperative study
237 Citations1976J.‐P. Lacour, P. Bucalossi +6 more
There is no indication for extended mastectomy in any cancers of the outer quadrants or in those of the inner or medial quadrants without axillary involvement, and a limited indication forextended mastectomy may be provisionally retained for T1 and T2 cancers ofThe outer quadrant with axillary involved.
CancerA randomized comparative trial of adriamycin versus methotrexate in combination drug therapy
232 Citations1978Joan M. Bull, Douglass C. Tormey +6 more
Although within acceptable limits, hematologic and GI toxicity was greater with CAF, and the therapeutic difference between the two therapies is a higher initial response rate to the adriamycin containing regimen.
CancerSurgical adjuvant chemotherapy.Results with one short course with cyclophosphamide after mastectomy for breast cancer
227 Citations1978R Nissen-Meyer, K Kjellgren +3 more
One single six‐day course with cyclophosphamide was given immediately after mastectomy to 507 breast cancer patients, with 519 randomized controls receiving no adjuvant chemotherapy, finding a definite reduction of recurrence rates due to tumoricidal chemotherapy.
CancerCombination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer
206 Citations1975Stephen E. Jones, Brian G.M. Durie +1 more
Chemotherapy with adriamycin and cyclophosphamide proved to be safe and effective for outpatient treatment of advanced breast cancer.
New England Journal of MedicineEstrogen Receptors and Responses to Chemotherapy and Hormonal Therapy in Advanced Breast Cancer
206 Citations1978David T. Kiang, Daniel H. Frenning +3 more
Analysis of clinical data of patients with advanced breast cancer suggests that separate factors associated with the response to chemotherapy may coexist with estrogen receptors in breast cancer.
CancerThe gross rates of growth of human mammary carcinoma
194 Citations1972Satoru Kusama, John S. Spratt +3 more
In a retrospective review of 912 patients with mammary cancer at the Ellis Fischel State Cancer Hospital, 199 patient records contained two or more gross measurements of a neoplastic focus in the breast, a lymph node, the lung, the chest wall, or other sites.
CancerLow incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication
193 Citations1977John S. Meyer, B. Ramanath Rao +2 more
It is concluded that dedifferentiation in breast carcinomas is associated with both high TLI and absence of ER, and suggested that the carcinomas with the most rapid proliferative rates will include the highest proportion of tumors unresponsive to hormonal therapy.
CancerPathologic findings from the national surgical adjuvant breast project (protocol no. 4).I. Observations concerning the multicentricity of mammary cancer
179 Citations1975Edwin R. Fisher, Remigio M. Gregorio +4 more
An attempt to correlate the occurrence of multicentric cancers with a large number of pathologic and some clinical features disclosed a statistically significant association between multicentricity and grossly nonencapsulated dominant cancers with maximum diameters greater than 5 cm, the presence of a moderate or marked intraductal component and noninvasive cancer in its vicinity, and tumor involvement of the nipple.
CancerPrognosis in breast cancer utilizing histologic characteristics of the primary tumor
174 Citations1975Maurice M. Black, T. H. C. Barclay +1 more
A positive association between the cellular responses to areas of in situ carcinoma and the cellular response to accompanying invasive breast cancer is found, adding to the general understanding of immunogenicity of breast cancer tissue.
CancerInflammatory carcinoma of the breast
173 Citations1978Fred V. Lucas, Carlos Perez‐Mesa
Either clinical or pathologic criteria justify use of the term “inflammatory breast carcinoma” to indicate short‐term prognosis despite available treatment, and patients with clinical inflammation had rapid deterioration.
Annals of Internal MedicineTamoxifen (Antiestrogen) Therapy in Advanced Breast Cancer
170 Citations1977David T. Kiang, BJ. KENNEDY
Tumors containing estrogen receptors and those that responded to previous hormonal manipulation tended to respond to tamoxifen (antiestrogen), 60% and 69%, respectively, and patients with receptor-negative tumor or with a history of failure of previous hormonal treatments did not respond.
CancerCombination chemotherapy for metastatic breast carcinoma.Prospective comparison of multiple drug therapy with L-phenylalanine mustard
169 Citations1976George P. Canellos, Stuart Pocock +4 more
The superior antitumor effect of CMF over L‐PAM suggests that it may be a more effective drug regimen to be used as an adjuvant to primary therapy.
PubMedCombination cancer therapy: Presidential address.
169 Citations1972Emil Frei
The needforthedevelopment of systemictreatment forcancer, theencouragement frommysuperiors, and theopportunity toobserve the verydramaticeffect that could beachievedoccasionallyintheleukemiasthroughtreatment developed byDr.GordonZubrodwhoprovided thefriendliness, stimulation, guidance, andOpportunitytowork, andhehascontinuedtodoso.
British Journal of RadiologyV. The Value of Simple Mastectomy and Radiotherapy in the Treatment of Cancer of the Breast
157 Citations1948R. W. P. McWhirter
The view has been expressed that the publication of results of selected cases has greatly confused the issue and has tended to convey the impression that radical mastectomy is a highly successful method of treatment of breast cancer.
PubMedBreast cancer in 3,558 women: age as a significant determinant in the rate of dying and causes of death.
152 Citations1978Mueller Cb, Frederick C. Ames +1 more
The forces of mortality created by cancer of the breast have been examined utilizing data collected during the past 19 years by the Syracuse, N. Y., Upstate Medical Center Cancer Registry on 3,558 women.
CancerL-phenylalanine mustard (L-PAM) in the management of primary breast cancer:An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU)
151 Citations1977Bernard Fisher, Andrew G. Glass +15 more
Findings from the second protocol confirm those previously reported indicating that L‐PAM lengthens the disease free interval following mastectomy and lend support to the thesis that since breast cancer is an eponym to describe a heterogeneous group of tumors residing in a heterogenous group of women, it is unlikely that uniformly qualitative and quantitative systemic regimens of therapy will be required for every patient.
The LancetOVARIAN FUNCTION IN PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST CANCER
151 Citations1977David P. Rose, T. E. Davis
Plasma-A2 fell after chemotherapy in the postmenopausal group; the other hormones were unchanged; the beneficial effects of adjuvant chemotherapy for breast cancer may result, in part, from suppression of ovarian function.
DrugsTamoxifen
150 Citations1978R.C. Heel, Rex N. Brogden +2 more
It nevertheless appears that tamoxifen is at least as effective as standard oestrogen or androgen therapy in postmenopausal women, while producing a lower incidence of troublesome adverse effects.
CancerCombination chemotherapy and adriamycin in patients with advanced breast cancer.A Southwest Oncology Group study
150 Citations1976Barth Hoogstraten, Stephen L. George +6 more
The weekly combination is the most effective therapy for patients with advanced disease and extensive trials of combinations that include adriamycin are underway.
CancerGrowth rates of primary breast cancers
149 Citations1979Louis S. Heuser, John S. Spratt +1 more
Growth rates of 32 primary breast cancers were determined from serial mammographic views of tumor nucleus shadows in a population of 109 cancers in a screening population of 10, 120 women receiving over 30,000 mammograms over 3 years.
International Journal of Radiation Oncology*Biology*PhysicsThe effect of post-operative radiotherapy in breast cancer
147 Citations1977Herman Høst, I. O. Brennhovd
BMJThe curability of breast cancer.
139 Citations1976W Duncan, G.R. Kerr
Analysis of age-correlated survival rates for women treated for localised breast cancer showed that those with smaller cancers had a significantly higher survival rate and a significantly reduced probability of dying of cancer.
MetabolismHormones in breast cancer: Update 1978
139 Citations1978William McGuire, Kathryn B. Horwitz +3 more
The use of ER assays in the primary breast tumor specimen to predict for early recurrence and ultimate survival is a new finding, however, and will probably be employed in future trials of adjuvant therapy.
CancerLocally recurrent carcinoma of the breast.Results of radiation therapy
137 Citations1976Florence C. H. Chu, Fang‐Jen Lin +3 more
Local relapse indicates a poor prognosis, but it is by no means totally hopeless, and radiation therapy was valuable in controlling local lesions, and thus, in improving quality of survival, even in patients who eventually died of metastatic disease.
CancerRadiation therapy as initial treatment for early stage cancer of the breast wiithout mastectomy
131 Citations1977Leonard R. Prosnitz, Ira S. Goldenberg +8 more
It is the conclusion that mastectomy is not a necessary part of the treatment of small breast cancers, that radiation withoutmastectomy is an acceptable alternative with far superior cosmetic and functional results, and adjuvant chemotherapy should be considered particularly in stage II patients in view of their 40% relapse rate.
Cancer1-Phenylalanine mustard (L-PAM) in the management of premenopausal patients with primary breast cancer.Lack of association of disease-free survival with depression of ovarian function
129 Citations1979Bernard Fisher, Barry M. Sherman +4 more
Breast cancer patients participating in a prospective randomized clinical trial who were ≤49 years of age, had positive axillary nodes, and who received prolonged l‐phenylalanine mustard as an adjuvant to mastectomy continue (after 4 years) to demonstrate a significantly greater disease‐free survival than do patients who received placebo.
CancerA comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer.A southeastern cancer study group project
127 Citations1977R V Smalley, John T. Carpenter +3 more
Responses, duration of response, and median duration of disease control achieved with CAF were superior to those achieved with CMFVP (37%, 22 weeks, 17 weeks, respectively).
Annals of SurgerySTUDY OF THE RESULTS OF OPERATIONS FOR THE CURE OF CANCER OF THE BREAST
124 Citations1932DEAN LEWIS, William F. Rienhoff
CancerThe influence of untreated internal mammary metastases upon the course of mammary cancer
122 Citations1977William L. Donegan
It was concluded that internal mammary metastases usually reflect generalized tumor spread and that local therapy directed at these nodes has a negligible influence upon cure of the disease.
BMJResponse and survival in advanced breast cancer after two non-cross-resistant combinations.
119 Citations1976Cristina Brambilla, M. De Lena +3 more
Results are comparable with those obtained with other multiple-drug regimens, and combination chemotherapy alone seems to have reached a plateau in its capacity to control disseminated breast cancer.
World Journal of SurgeryThe guy's trial of treatments of “early” breast cancer
116 Citations1977John L. Hayward
Between 1961 and 1971, 370 patients with stages I and II breast cancer were assigned by random sample to receive either wide local excision or standard radical mastectomy, and patients in both groups received postoperative radiotherapy which, admittedly, would be considered less than optimal nowadays for patients with an intact axilla.
CancerResults of treating stage iii carcinoma of the breast by primary radiation therapy
115 Citations1979James E. Bruckman, Jay R. Harris +3 more
The results indicate that primary radiation therapy can provide local control in a high proportion of patients with stage III carcinoma of the breast and suggest that chemotherapy is effective in improving both local control and survival in these patients.
PubMedEstradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels.
115 Citations1978S Saez, Pierre Martin +1 more
The data suggest that the circulating levels of estrogen in post menopausal women are sufficient to stimulate ER and PGR when ER is functional, and in premenopausal women, high levels of circulating progesterone may inhibit PGR, and the absence of PGR in the breast cancers of premenographic women should be interpreted warily if the plasma level of progester one is unknown.
CancerPreliminary trial of aminoglutethimide in breast cancer
110 Citations1973C. Thomas Griffiths, Thomas C. Hall +3 more
Dose‐related CNS toxicity, ranging from drowsiness to semi‐coma, predominated but relative hypoadrenocorticism may have contributed, and concurrent pharmacologic doses of glucocorticoids may reduce toxicity and inhibit compensatory ACTH secretion.
PubMedProliferation kinetics of a human breast cancer line in vitro following treatment with 17beta-estradiol and 1-beta-D-arabinofuranosylcytosine.
109 Citations1978Ralph R. Weichselbaum, Samuel Hellmän +3 more
Kinetic changes caused by hormones have profound implications in clinical therapy, since the efficacy of cycle active agents may be altered.
BMJCyclical Combination Chemotherapy for Advanced Breast Carcinoma
106 Citations1974George P. Canellos, Vincent T. DeVita +4 more
Twenty-five patients with advanced metastatic breast cancer were treated with the combination of methotrexate and 5-fluorouracil intravenously and by mouth daily for the first 14 days of a 28-day cycle, with no correlation between the length of the metastasis-free interval after previous treatment and subsequent response to chemotherapy.
CancerImmunofluorescent detection of estrogen receptors in breast cancer.Comparison with dextran-coated charcoal and sucrose gradient assays
104 Citations1978Louis P. Pertschuk, Ellis Tobin +7 more
Biopsy specimens from 106 women with primary operable, recurrent or metastatic breast cancer were analyzed in a double blind study designed to compare the results of a new fluorescent antibody method for detection of estrogen receptors with estrogen receptors measured biochemically with dextran‐coated charcoal and sucrose gradient assay techniques.
American Journal of Clinical PathologyPathologic Findings from the National Surgical Adjuvant Breast Project (Protocol No. 4): III. The Significance of Extranodal Extension of Axillary Metastases
104 Citations1976Edwin R. Fisher, Remigio M. Gregorio +3 more
The results suggest that evaluation of extranodal extension of axillary nodal metastases in patients with breast cancer may represent an important prognostic discriminant.
New England Journal of MedicineLack of Efficacy of Thermography as a Screening Tool for Minimal and Stage I Breast Cancer
104 Citations1976Myron Moskowitz, John R. Milbrath +3 more
CancerFactors affecting estrogen receptors in breast cancer
104 Citations1977David T. Kiang, B. J. Kennedy
The incidence of the presence of estrogen receptors (ER+) increased in the order of para‐, pre‐ and postmenopausal status of the patient, suggesting that a tumor occurring at the paramenopausal phase tends to be a hormoneindependent type.
New England Journal of MedicineTrends in Survival Rates of Patients with Cancer
103 Citations1975Sidney J. Cutler, Max H. Myers +1 more
Reports on survival of patients with cancer issued by the National Cancer Institute indicate marked improvement for almost all forms of cancer from the 1940's to 1950's, but little improvement in patient survival during the 1960's was observed, and for women with invasive cervical cancer, survival rates decreased slightly.
CancerConsecutive primary carcinomas of the breast
103 Citations1975J. A. McCredie, W. R. Inch +1 more
The incidence of consecutive primary carcinoma of the breast in 1489 women was 1% per year and remained constant for 20 years and the age of women with bilateral carcinomas was 6 years younger than those who had single tumors.
CancerAntihormone treatment of stage IV breast cancer
101 Citations1979Andrea Manni, J. Trujillo +3 more
The antiestrogen Tamoxifen (T), given orally to 113 patients with stage IV breast cancer, induced objective remission in 50% and induced further palliation after treatment with T, indicating that pituitary hormones may also play a role in the growth of some human breast cancers.
CancerMedical adrenalectomy using aminoglutethimide and dexamethasone in advanced breast cancer
98 Citations1974Allan Lipton, Richard J. Santen
The American Journal of SurgeryHypophysectomy in the treatment of metastatic mammary cancer
96 Citations1960Olof H. Pearson, Bronson S. Ray
Hypophysectomy is recommended as the initial systemic treatment of choice in postmenopausal patients and in those who have had a previous favorable response from oophorectomy, when adequate facilities are available to perform this procedure.
BMJRecurrent breast cancer treated with the antioestrogen tamoxifen: correlation between hormonal changes and clinical course.
94 Citations1977K. J. WILLIS, David London +4 more
Patients seem to have a better chance of responding to anti-oestrogen treatment if prolactin secretion is low, and responses to luteinising hormone-releasing hormone did not change, and androgen concentrations remained within the normal range in all patients.
CancerAdriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer. A randomized trial
93 Citations1978Hyman B. Muss, Dougľas R. White +6 more
Although statistical significance was not reached at the 5% level, the increased survival of responders on the Adriamycin regimen supports the data of other studies which suggest that first line combination chemotherapy in advanced breast cancer should include AdRIamycin.
PubMedDiethylstilbestrol: recommended dosages for different categories of breast cancer patients. Report of the Cooperative Breast Cancer Group.
92 Citations1977Anne C. Carter, Nell Sedransk +5 more
Annals of SurgeryMedical Adrenalectomy with Aminoglutethimide
90 Citations1978Samuel A. Wells, Richard J. Santen +5 more
The medical adrenalectomy regimen of aminoglutethimide plus glucocorticoid offers a suitable alternative to surgical adrenal surgery or hypophysectomy in the management of postmenopausal patients with metastatic breast carcinoma.
International Journal of Radiation Oncology*Biology*PhysicsDoes adequate irradiation of the internal mammary chain and supraclavicular nodes improve survival rates?
90 Citations1978Gilbert H. Fletcher, Eleanor D. Montague
Data suggests strongly that the irradiation of peripheral lymphatics has been curative in a significant number of patients, particularly among the irradiated patients with histologically positive axillary nodes.
CancerImpact of tumor grade and host resistance on survival of women with breast cancer
88 Citations1971H. J. G. Bloom, John R. Field
A series of 1,411 cases of breast cancer has been used to demonstrate the role of morphological factors relating to tumor malignancy and to host resistance in assessing more accurately prognosis and the value of various treatments.
The LancetAMINOGLUTETHIMIDE IN TREATMENT OF METASTATIC BREAST CARCINOMA
88 Citations1978Ian E. Smith, Bernie Fitzharris +7 more
42 patients with metastatic breast carcinoma were treated with aminoglutethimide, which inhibits adrenal steroid hormone synthesis, and response was commonest in patients who had previously responded to other forms of endocrine therapy.
CancerNatural history of breast cancer:Progression from hyperplasia to neoplasia as predicted by angiogenesis
87 Citations1977Pietro M. Gullino
Evidence from the laboratory suggests that progression from hyperplasia to neoplasia can be evaluated by determining whether mammary tissue has acquired the capacity to induce new formation of vessels in the host tissue, and if the angiogenic property of hyperplastic epithelium can identify women with a mammary parenchyma at higher risk of developing breast carcinoma, a powerful tool is available for predicting neoplastic transformation before clinical manifestations.
CancerKinetic, hormonal and clinical studies with aminoglutethimide in breast cancer
87 Citations1977Richard J. Santen, E Samojlik +5 more
The present aminoglutethimide‐hydrocortisone regimen is simple, non‐toxic, effective in inhibiting estradiol synthesis and capable of inducing tumor regression as frequently as previously reported with adrenalectomy.
Cancer Treatment ReviewsAntiestrogens in the treatment of breast cancer
84 Citations1976Sewa S. Legha, Stephen K. Carter
Antiestrogens can be used as an alternative to major endocrine ablation especially in patients who have previously responded to estrogens or who have ER-positive tumors and Combination of antiestrogens with antiprolactin therapy may be a substitute for hypophysectomy.
CancerBreast cancfr–-influence of growth rate on prognosis and treatment evaluation.A study based on mastectomy scar recurrences
83 Citations1976Alexander Pearlman
The appreciable number of patients with tumors exhibiting slow or intermediate growth rates, in any series, suggests that the use of the 5‐year interval is an inadequate measure of therapeutic response in breast cancer and may actually be misleading.
Annals of SurgeryLocal Excision and Irradiation
83 Citations1971Leslie Wise, Aubrey York Mason +1 more
British Journal of RadiologyThe number of patients required in a clinical trial
81 Citations1971J. W. Boag, J. L. Haybittle +2 more
Two widely different estimates of patient numbers to be found in recent radiological literature reflect these different approaches to the question and an attempt is made below to explain how these differences arise.
CancerAnalysis of survival and recurrence vs. patient and doctor delay in treatment of breast cancer
81 Citations1975C Dennis, Bernard Gardner +1 more
Two hundred thirty‐seven patients with cancer of the breast treated with radical mastectomy were reviewed and no significant relationship between delay and time of recurrence was found.
BMJChemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.
78 Citations1976Jordan U. Gutterman, JUAN O. CARDENAS +8 more
Although the apparent benefit of BCG could be explained by a maldistribution of some prognostic factors, the data suggest that further trial of chemoimmunotherapy of breast cancer should be carried out.
Annals of Internal MedicineTreatment of Breast Cancer with Medroxyprogesterone Acetate
78 Citations1968Franco M. Muggia, PETER A. CASSILETH +4 more
The prolonged administration of large doses of medroxyprogesterone acetate (MPA) in the treatment of patients with disseminated breast cancer was studied and 3 of the 7 patients continued in remission at writing, 2 had succumbed to the disease, and 2 were receiving other agents.
New England Journal of MedicineProlactin and Breast Carcinoma
77 Citations1975Francine Smithline, Lawrence Sherman +1 more
In vitro determination of the presence of prolactin receptors in human breast tumor tissue may allow accurate prediction of response to endocrine ablation.
PubMedSubpopulations of breast carcinoma defined by S-phase fraction, morphology, and estrogen receptor content.
76 Citations1978Jerrold S. Meyer, Bauer Wc +1 more
Correlations between SPF, estrogen receptor content, and microscopic morphology indicate the existence of distinctive subpopulations of breast carcinoma that may have epidemiologic and therapeutic importance.
CancerChemotherapy of disseminated breast cancer:Current status and prospects
75 Citations1977Paul P. Carbone, Madeline Bauer +2 more
Since most patients with breast cancer present with local or regional disease but go on to die of disseminated cancer, major improvements in survival are most likely to occur by treating this neoplasm as a systemic disease through combining effective local therapy with systemic treatments.
CancerCombined chemo- and hormonal therapy in advanced breast cancer
74 Citations1977Kurt Brunner, Roland Sonntag +5 more
In a randomized study of 213 evaluable patients, a combination of hormone and polyChemotherapy was compared with polychemotherapy alone and results are analyzed according to dominant metastatic site, age groups, and intervals from diagnosis to the beginning of protocol therapy.
CancerPituitary-ovarian function in breast cancer patients on adjuvant chemoimmunotherapy
71 Citations1978Naguib A. Samaan, Diosdado N. Deasis +2 more
The results indicate that amenorrhea that develops in some patients with breast cancer after FAC‐BCG therapy is a result of primary ovarian failure.
PubMedCombination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast.
71 Citations1976Richard V. Smalley, Scott Murphy +2 more
The median survival for either group treated with combination therapy was double that of patients on sequential therapy, and one-fourth of the patients had a prolonged survival (greater than 75 weeks), regardless of therapy.
CancerIntensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancer
70 Citations1978Aman U. Buzdar, Jordan U. Gutterman +7 more
British journal of surgeryThe treatment of operable cancer of the breast: A clinical trial in the South East Region of Scotland
68 Citations1974Thomas W. Hamilton, A.O. Langlands +1 more
Surgeons and radiotherapists of the SouthEast Region of Scotland agreed to collaborate in a randomized prospective study to compare this form of treatment with standard radical mastectomy with success.
Annals of SurgeryEstrogen Receptor and Natural Course of Breast Cancer
67 Citations1976Amnuay Singhakowinta, Henry G. Potter +4 more
JAMAAndrogenic Therapy for Advanced Breast Cancer in Women
67 Citations1973Ira S. Goldenberg
Effectiveness of the calusterone has prompted a dose-response study by the CBCG to determine the most effective dose of this androgen for use in treatment of breast cancer.
BMJAntioestrogens in Treatment of Breast Cancer: Value of Nafoxidine in 52 Advanced Cases
65 Citations1974H. J. G. Bloom, E. Boesen
The synthetic non-steroidal antioestrogen nafoxidine (U-11, 100A) was given by mouth to 52 women with locally advanced or metastatic breast cancer, in 85% of whom the disease had become resistant to, or relapsed after, previous endocrine treatment.
…